Biomea Fusion BMEA
NASDAQ BMEA
$1.76 +0.05 (+2.92%)
As of: Sep 22, 2026 · 11:18 AM EDT

Biomea Fusion (BMEA) Cash from Financing Activities (2020 - 2025)

Biomea Fusion's (BMEA) quarterly Cash from Financing Activities came in at $23.1 million in Q4 2025, up 5496.13% year-over-year from $413000.0 in Q4 2024, and up 1074.39% quarter-over-quarter from $2.0 million in Q3 2025.

Analysis

Biomea Fusion (BMEA) Cash from Financing Activities (2020 - 2025) Analysis & Trends

Biomea Fusion has disclosed Cash from Financing Activities across 6 years of filings, most recently posting $23.1 million for Q4 2025.

  • In Q4 2025, Cash from Financing Activities rose 5496.13% year-over-year to $23.1 million; the TTM figure through Dec 2025 stood at $67.9 million (up 3970.98% YoY), while the FY2025 annual figure was $67.9 million, up 3970.98% from the prior year.
  • Cash from Financing Activities came in at $23.1 million for Q4 2025 at Biomea Fusion, up from $2.0 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $162.8 million in Q2 2023 to a low of -$3000.0 in Q1 2021.
  • Average Cash from Financing Activities over 5 years is $20.4 million, with a median of $413000.0 recorded in 2024.
  • Year-over-year, Cash from Financing Activities tumbled 106.0% in 2021 and soared 51106.6% in 2023.
  • Over 5 years, Cash from Financing Activities stood at $246000.0 in 2021, then jumped by 99.19% to $490000.0 in 2022, then grew by 26.94% to $622000.0 in 2023, then slumped by 33.6% to $413000.0 in 2024, then surged by 5496.13% to $23.1 million in 2025.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were $23.1 million in Q4 2025, $2.0 million in Q3 2025, and $39.6 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn -8.78 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -5.05 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -2.02 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -3.66 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn -2.63 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn -2.10 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn - 2.42 Bn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn -6.05 Mn
10 Biomea Fusion 132.65 Mn 132.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 23.11 Mn
Sep 30, 2025 1.97 Mn
Jun 30, 2025 39.57 Mn
Mar 31, 2025 3.25 Mn
Dec 31, 2024 413,000.00
Sep 30, 2024 69,000.00
Jun 30, 2024 1.07 Mn
Mar 31, 2024 116,000.00
Dec 31, 2023 622,000.00
Sep 30, 2023 138,000.00
Jun 30, 2023 162.84 Mn
Mar 31, 2023 201,000.00
Dec 31, 2022 490,000.00
Sep 30, 2022 400,000.00
Jun 30, 2022 318,000.00
Mar 31, 2022 31,000.00
Dec 31, 2021 246,000.00
Jun 30, 2021 152.94 Mn
Mar 31, 2021 -3,000.00
Dec 31, 2020 56.39 Mn
API Access

Biomea Fusion Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=BMEA&period=max&api_key=YOUR_API_KEY